Innovator IBD Breakout Opportunities ETF Rating $44.70 -0.02 (-0.04%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsBuy This Stock Innovator IBD Breakout Opportunities ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BOUT Aggregate RatingModerate Buy 2.73Holdings in BOUT have an aggregate rating of Moderate Buy based on 305 analyst ratings issued in the past year covering 24 companies (95.9% of the portfolio).BOUT Aggregate Price Target$44.67-0.07% DownsideHigh Prediction$44.67Average Prediction$44.67Low Prediction$44.67Holdings in BOUT have an aggregate price target of $44.67 and a range of $44.67 to $44.67 covering 24 companies (95.9% of the portfolio).BOUT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD Breakout Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BOUT Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.62%ELVNEnliven Therapeutics$58.82+1.3%3.2297 of 5 stars2.71$72.67 23.5%77.12%GKOSGlaukos$185.01-2.3%2.4257 of 5 stars2.73$177.33 -4.1%15Insider Trade7.04%BCAXBicara Therapeutics$24.28+2.8%2.0902 of 5 stars2.73$32.73 34.8%15News CoverageEarnings ReportAnalyst ForecastInsider TradeGap Down7.02%USBU.S. Bancorp$65.39+0.3%4.477 of 5 stars2.72$67.06 2.6%25Positive News6.32%TPRTapestry$129.11+0.6%4.5075 of 5 stars2.80$175.13 35.6%20Trending NewsEarnings ReportDividend IncreaseAnalyst ForecastHigh Trading Volume6.32%LQDALiquidia$74.44+3.2%4.5367 of 5 stars2.64$98.08 31.8%11Trending NewsEarnings ReportAnalyst DowngradeAnalyst Revision6.01%PNCThe PNC Financial Services Group$256.91+0.7%4.5644 of 5 stars2.86$265.73 3.4%22Positive NewsInsider Trade5.89%OSCROscar Health$32.68+6.2%4.4238 of 5 stars2.42$26.22 -19.8%12Analyst Upgrade5.83%DAVEDave$334.57+0.2%4.3446 of 5 stars2.79$412.90 23.4%145.66%TGTXTG Therapeutics$48.74+1.7%4.3834 of 5 stars2.44$63.00 29.3%94.08%KNSAKiniksa Pharmaceuticals International$76.75-1.4%4.1824 of 5 stars2.90$87.38 13.8%10Positive News4.06%TILEInterface$37.96-2.0%3.6309 of 5 stars2.75$40.50 6.7%4Earnings ReportAnalyst Upgrade4.03%BACBank of America$64.46+0.6%4.4125 of 5 stars2.78$64.08 -0.6%27Trending NewsAnalyst Revision4.03%VIKViking$97.61-8.0%4.2935 of 5 stars2.79$106.22 8.8%19Upcoming EarningsAnalyst Forecast2.02%RJFRaymond James Financial$180.85-0.1%3.3997 of 5 stars2.38$181.00 0.1%132.01%BNYBank of New York Mellon$163.30+0.6%4.3116 of 5 stars2.82$157.13 -3.8%17Analyst Revision2.00%PNFPPinnacle Financial Partners$107.94+0.7%4.9675 of 5 stars2.89$118.35 9.6%191.99%FBKFB Financial$61.88-0.3%3.5669 of 5 stars3.14$64.67 4.5%7Ex-Dividend1.87%CHEFChefs' Warehouse$109.08-2.7%2.4565 of 5 stars2.88$107.43 -1.5%8Positive NewsAnalyst UpgradeHigh Trading Volume1.02%GRMNGarmin$310.66-0.4%4.5227 of 5 stars2.86$310.17 -0.2%7Trending NewsAnalyst Revision1.00%IFSIntercorp Financial Services$54.73+0.1%4.6998 of 5 stars3.00$56.00 2.3%3News CoverageEarnings Report1.00%ENVAEnova International$265.93+1.5%3.4172 of 5 stars3.11$247.83 -6.8%90.99%NWGNatWest Group$19.11-1.1%3.3917 of 5 stars2.7170.97%CARECarter Bankshares$32.70+0.1%3.0863 of 5 stars2.20$30.75 -6.0%5 This page (NYSEARCA:BOUT) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredOne wafer-scale chip does in minutes what AI takes daysNVIDIA has dominated the AI computing race, but history shows even titans can be dethroned, just ask IBM. T...Eagle Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD Breakout Opportunities ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
